Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The CON that Koos is playing, straight from the 10K
Read this carefully, especially the last part of who got the remaining shares of ONPH that Koos had.
During the quarter ended December 31, 2021 the Company paid $5,000 of rental expenses to the landlord of BST Partners as consideration to BST Partners for use of office space. BST Partners is controlled by David R. Koos the Chairman and Chief Executive Officer of the Company.
On January 13, 2022 Regen Biopharma, Inc. entered into a sublease agreement with BST Partners (“BST”) whereby Regen Biopharma, Inc. would sublet office space located at 4700 Spring Street, Suite 304, La Mesa, California 91942 from BST on a month to month basis for $5,000 per month beginning January 14, 2022.
BST Partners is controlled by David Koos who serves as the sole officer and director of Regen Biopharma, Inc.
On August 8, 2022 the Company sold 18,200 common shares of Oncology Pharma, Inc. to Zander Therapeutics, Inc. for consideration consisting of $25,000 cash.
Only .1751 cents more to go before that happens.
And remember, don't be surprised to wake up tomorrow seeing this at .18 cents because Koos said so in the 10K!
So how did this go up with so much naked shorting happening today?
And that's the little financial scam he has going on.
The lower the pps goes, the more ridiculous the hyperbole gets on just how wonderful the company is and its prospects. Anyone honest about this stock knows this.
I am disappointed that no one is posting those links to the marketing research ads where they want you to pay $3500 to realize that RGBP is only being mentioned with the other big pharmas so that you get suckered into paying $3500 to learn absolutely nothing about Regen. Remember those and the "LOOK, REGEN IS BEING MENTIONED WITH PFIZER, J&J, MERCK, etc" as a reason why Regen is about to take off?
Putting all the ridiculous hyping we see on here, many need to come to grips that this stock is a pinkie stinky for one reason. And that's because it is a bogus company that has ZERO prospects in starting a legit pipeline with FDA approved clinical trials.
Correct because one day we'll wake up and it will...wait for it...wait for it....BE AT $1!!!
WOO HOO!
We are on day 634 since someone posted that prediction. 2.24.21 to be exact.
Naked shorting didn't take the pps down. Know what did? All of the shares of dilution being printed and issued by your buddy Diluting Dave. See all of those shares he's been printing in the 10K? Well, did ya?
Oh, what about that outstanding debt you said was ALL paid off? Did you read the 10K? Well, did you? If you did, you'll see there is plenty of debt still owed on the books.
Did you also see this doozy? I bolded and underlined the most salient parts that refute the misinformation putting forth on here that the INDs are active. They are certainly not. And to date, what exactly did BRG tell Koos? I think they told him he will need to redo all the preclinical testing. And remember we were wrongly told that BRG was going to VALUE the company. That wasn't what BRG did and I told people, yet again, on here that that wasn't was BRG was doing. Oh, all the misinformation I have to correct on here.
I suggest reading this out loud:
On May 12, 2021 the “Company executed a consulting agreement with Biotech Research Group Corporation, an FDA Specialist Group and Global Regulatory and Scientific Experts, for the purpose of review and guidance with regard to the planned reinstatement of the Company’s inactive Investigational New Drug applications (INDs) #15376 (HemaXellerate) and #16200 (dCellVax) filed with the United States Food and Drug Administration (“FDA”). The securing of the services to be provided to the Company pursuant to this consulting agreement marks the first step taken by the Company with regard to activating the Company’s currently inactive applications to initiate clinical trials[/u]
And where is Brian? Where is the white paper? Where are the introductions? Where is the CSO?
On October 8,2021 the Company entered into an agreement with Dr. Brian Koos, MD PhD whereby Dr. Brian Koos would provide services to the Company consisting of :
a) Reviewing existing publications on research being conducted on Checkpoint NR2F6.
b) Identifying the most promising applications for the Company’s technology
c) Drafting a “white paper” on results for 1(b)
d) Making introductions to known experts in appropriate fields identified in 1(b).
Dr. Brian Koos is to be paid compensated $117,000 as total consideration for performing the abovementioned tasks. During the quarter ended December 31, 2021 Dr. Brian Koos was paid the amount of $80,275 and during the quarter ended March 31, 2022 Dr. Brian Koos was paid $36,975. Dr. Brian Koos is the brother of David Koos the Chairman and Chief Executive Officer of the Company.
And it is still no where near 8 cents!
What is that all about?
Talking about Fudpuckers, did Koos mention anything about the lilly partnership during his concall? What about the partnership with Dyo since Lyin' Lander was on the call too?
Oh wait. Fudpucker Koos didn't mention a thing about either because....wait for it....wait for it....NEITHER ARE ACTUALLY IN EXISTENCE!
YES, THAT'S RIGHT! NO PARTNERSHP EVER EXISTED WITH LILLY. AND THE SO CALLED "FAST TRACK" PARTNERSHIP WITH DIEDYO BIO WAS ABOUT AS MUCH A PARTNERSHP AS THE BUYING OF CANARY WAS! BOTH NEVER MATERIALIZED BECAUSE THEY WERE ALL A PR SCAM!
I guess it takes a fudpucker to know a fudpucker, amirite?
Talking about fudpuckers, did Koos ever get his brother to write that White Paper or did Brian just take the $117K and say "see ya!"
And funny that absolutely no one seems to care that Koos can't even deliver on that and the hiring of a CSO.
Pretty sad.
Let me expose just how wrong you are
If there is this naked shorting of the stock, why hasn’t Konman koos brought this up?
Let’s explore this.
1. He knows it isn’t happening and that’s why he isn’t addressing it. It isn’t like anyone who is chirping about is asking him to address it.
2. He knows it is happening but isn’t addressing it. That would further explain his incompetence as ceo.
3. He knows about it and is staying quiet because he is the one doing it.
When you analyze the above, one can only rationally come to the conclusion that the claim of naked shorting a sub penny stock is just misinformation.
Today's action had nothing to do with naked shorters or MMs. If anything, the MMs did their job in moving 10s of millions of worthless shares to gamblers who think this is going to sky rocket again.
That might happen if the promotion websites can get more naive gamblers to buy worthless shares by pushing the narrative that this is going to be bought out etc.
But that only works every so often and those two times it happened sorta wiped out the hope it will happen a third time.
The two catalysts that will only move the pps is a buy out or a deal with a major and credible pharma not named oncofakeapharma.
Odds of those two things happening are .0045%.
But lest one forgets, let's go back to the grandiose predictions that fell flat
https://www.reddit.com/r/RGBP/comments/pcc2zj/top_5_big_pharma_rgbp_buy_out_candidates/
Gotta think that anyone with any sense realizes that Regen is fool's gold and that the data being presented by fintel is not what it is being reported as being. Again, misinformation.
Koos issued the sharts to pay off his bar tab and losing donkey race bets in Tijuana. The cartel is not happy he hasn't paid it yet
Good job on calling the huge pancaking of the PPS today!
Looks like some are now seriously in the red.
Why is the stock tanking?
Yet again, I was and AM RIGHT. 99.49% right.
Could it be the additional 300,000,000 Preferred A shares he just added to the books?
This is a doozy.
This is what Koos the "business leader" does to his shareholders. There is only one person that benefits from this and it is Koos.
Series A:
From the last available 10Q
As of July 17, 2022 Regen Biopharma, Inc. had 439,293,406 shares of Series A Preferred Stock outstanding.
It is now 739,000,000.
He just increased it by 300,000,000.
Yep, he's a business leader!
LOL ROFLPIMPL!!!
Someone dumped 20+ million shares. Dilution or realization that they know they bought a stinker out a stock?
Do you think Lander will be able to get his buddies over at Cornell to throw Regen a penny of that grant fund?
HIGHLY DOUBT IT!
https://reporter.nih.gov/search/UCo8lWAeaU6jsHha15aNVw/project-details/10505675
As suspect, $RGBP back in the .004 range.
Lander is most likely desperate as all of his other bogus companies have likely folded up, just like Dyo. Koos is probably letting him sleep on his couch in his $5000/mo work/live condo.
No. Never had shares to begin with. Most likely another gambler dumping who realized he was misled by misinformation posted on otc message boards and who is thinking, "Gee, I should have done better DD. Sid wad right. Shoulda listened to him." Or, a note holder dumping.
LOL ROFL PIMPL
But back to the .004s!
Not surprising at all.
I miss the predictions of "1 cent by Friday" posts. It's been over a month and yet the pps can not get anywhere near 1 cent.
Why is that?
And I also keep waking up to be surprised that the pps is at $1 and yet that hasn't happened in two years of that prediction.
Why is that?
The pps is lower after the infamous Koos KONcall when we were told it would be a game changer.
Why is that?
I am still waiting to read that white paper written by David's brother Brian --who was paid $117K to do so -- and yet nothing after 11 months when it takes just a few days to write.
Why is that?
Dyo bio was supposed to help Regen fast track their pipeline and yet no fast track and Dyo Bio doesn't seem to be in business anymore.
Why is that?
A lot of questions and no answers from Koos.
We know WHY THAT IS. Koos is all talk and no action. That's a fact.
All of what you wrote is 100% true. The only big issue is that Koos has no money to continue said testing. And in the world of biotechs having money to do your testing, especially when it comes to clinical trials, is the only thing that matters. And we have past evidence that Koos is unable to raise money for clinical trials, not unlike its non big pharma battle Oncofakeapharma. Both keep telling us what they want to do but have yet to actually show they can do it.
And that's why the stock is where it is and going no where fast.
Many can't seem to grasp this simple reality and continue to buy into the misinformation posted here.
Great analysis and right on target. There is a reason why we haven't read any glowing reviews of the KONcall by the Konman and his side kick lyin' Lander. The silence is quite amazing to be honest. I was sure I'd see some positive spin on the horrible KONcall but I think many were just severely embarrassed by what they saw and realized I am actually right about the guy.
It was all fluff and a rehash of what we already know. I clearly stated that is what we'd hear and we did. It's the same song and dance by the konman.
Things must be really bad for Lander if he has to come crawling back to Koos and Regen.
There are many like yourself that would like to get their money back after realizing Koos is really bad at his job of building a biotech. What he is good at doing is utilizing an OTC company to fund his lifestyle, i'll give him that.
What ever happened to that deal with Oncopharma? Did Onco ever do anything with the IP it licensed? I was told repeatedly that onco was a big pharma that had the resources to get drugs approved and that Koos hit a homerun with the deal.
It is very perplexing that Koos didn't mention the onco pharma deal in his concall. Nor did he mention Dyo Bio and even Lander wasn't introduced as being part of Dyo Bio.
One can only believe that all of those so called deals were just a facade to try and pump the pps up. It worked initially but there was only ONE person who CORRECTLY called those deals as never going to do squat. That was me.
When one is based in reality, one can see the fraud very clearly.
As suspect! No gains this week, just losses. And to make matters worse, Koos opening his big FAT FILTHY PIE HOLE OF A MOUTH made things worse where the gamblers holding shares realize he is all talk and NO ACTION.
But anyone who knows how he operates knows that.
No gaslighting here.
The facts speak for themselves.
Koos and Lander are both losers.
He sounds really desperate to make up his losses. That's what unscrupulous gamblers on the OTC do.
Not ONE of his twitter predictions have come true.
Still waiting for that Kite like buyout.
celebration pancakes when this dips into the .004s?
For those who want to look at a real mRNA company, with real management and real scientists with real funding and a real future, look at this:
https://finance.yahoo.com/news/curevac-presents-preliminary-data-phase-122000800.html
Read the pr carefully because you will NEVER read the same coming from the fat bastard aka deadbeat dave aka konman Koos.